Research peptides
What each compound is, how much human evidence exists, where it's legal, and what it costs. Ordered by demand: how widely each one is sold, tested and discussed. We never publish dosing instructions.
| Peptide | Evidence | Vendors priced | Median $/mg |
|---|---|---|---|
| Semaglutide | Approved drug (in at least one market) | 19 | $4.89/mg |
| Retatrutide | Late-stage human trials | 22 | $4.69/mg |
| Tirzepatide | Approved drug (in at least one market) | 22 | $3.46/mg |
| BPC-157 | Preclinical (lab and animal studies) | 82 | $5.28/mg |
| GHK-Cu | Preclinical (lab and animal studies) | 91 | $0.590/mg |
| Cagrilintide | Late-stage human trials | 61 | $8.90/mg |
| TB-500 | Preclinical (lab and animal studies) | 80 | $6.17/mg |
| Tesamorelin | Approved drug (in at least one market) | 78 | $6.62/mg |
| CJC-1295 with DAC | Early human trials | 31 | $10.40/mg |
| Ipamorelin | Early human trials | 77 | $5.42/mg |
| NAD+ | Early human trials | 70 | $0.100/mg |
| MOTS-c | Preclinical (lab and animal studies) | 81 | $3.45/mg |
| BPC-157 + TB-500 blend | Preclinical (lab and animal studies) | 41 | $4.67/mg |
| PT-141 (bremelanotide) | Approved drug (in at least one market) | 66 | $4.00/mg |
| Semax | Early human trials | 57 | $3.58/mg |
| Melanotan II | Early human trials | 60 | $3.50/mg |
| KPV | Preclinical (lab and animal studies) | 67 | $4.60/mg |
| KLOW blend (GHK-Cu + KPV + BPC-157 + TB-500) | Preclinical (lab and animal studies) | 16 | $1.57/mg |
| SS-31 (elamipretide) | Approved drug (in at least one market) | 47 | $3.55/mg |
| Selank | Early human trials | 57 | $3.98/mg |
| Epitalon | Preclinical (lab and animal studies) | 75 | $3.00/mg |
| GLOW blend (GHK-Cu + BPC-157 + TB-500) | Preclinical (lab and animal studies) | 13 | $1.34/mg |
| Sermorelin | Formerly approved drug (approvals withdrawn) | 62 | $7.50/mg |
| DSIP | Early human trials | 64 | $5.10/mg |
| Survodutide | Late-stage human trials | 11 | $9.95/mg |
| Glutathione | Approved drug (in at least one market) | 57 | $0.047/mg |
| AOD-9604 | Early human trials | 56 | $8.80/mg |
| Mazdutide | Late-stage human trials | 10 | $8.95/mg |
| Kisspeptin-10 | Early human trials | 49 | $5.28/mg |
| Thymosin Alpha-1 | Approved drug (in at least one market) | 61 | $6.50/mg |
| Pinealon | Preclinical (lab and animal studies) | 39 | $3.30/mg |
| Melanotan I | Approved drug (in at least one market) | 38 | $3.41/mg |
| Oxytocin | Approved drug (in at least one market) | 36 | $6.16/mg |
| ARA-290 (cibinetide) | Early human trials | 48 | $4.63/mg |
| GHRP-6 | Early human trials | 23 | $4.60/mg |
| Dihexa | Preclinical (lab and animal studies) | 5 | $18.80/mg |
| VIP (vasoactive intestinal peptide) | Approved drug (in at least one market) | 37 | $7.50/mg |
| LL-37 | Early human trials | 39 | $8.50/mg |
| IGF-1 LR3 | Preclinical (lab and animal studies) | 51 | $70.80/mg |
| CJC-1295 + Ipamorelin blend | Early human trials | 47 | $5.20/mg |
| GHRP-2 | Early human trials | 23 | $4.60/mg |
| Thymalin | — | 22 | $3.50/mg |
| Hexarelin | Early human trials | 19 | $8.00/mg |
| Cerebrolysin | Approved drug (in at least one market) | 14 | $1.07/mg |
| Humanin | Preclinical (lab and animal studies) | 11 | $9.09/mg |
| FOXO4-DRI | Preclinical (lab and animal studies) | 16 | $20.85/mg |
| Gonadorelin | Approved drug (in at least one market) | 10 | $6.57/mg |
| Follistatin | Preclinical (lab and animal studies) | 12 | $111.96/mg |
| Liraglutide | Approved drug (in at least one market) | 2 | $20.20/mg |
| ACE-031 | Early human trials | 7 | $109.45/mg |
| 5-Amino-1MQ | Preclinical (lab and animal studies) | 57 | $2.90/mg |
| Adipotide | Preclinical (lab and animal studies) | 14 | $10.15/mg |
| AHK-Cu | Preclinical (lab and animal studies) | 24 | $0.615/mg |
| Bronchogen | Preclinical (lab and animal studies) | 9 | $2.23/mg |
| Cagrilintide + Semaglutide blend | Late-stage human trials | 5 | $8.90/mg |
| Cardiogen | Preclinical (lab and animal studies) | 19 | $2.75/mg |
| Cartalax | Preclinical (lab and animal studies) | 32 | $2.75/mg |
| Chonluten | Preclinical (lab and animal studies) | 9 | $2.88/mg |
| CJC-1295 without DAC (Mod GRF 1-29) | Preclinical (lab and animal studies) | 67 | $6.80/mg |
| Cortagen | Preclinical (lab and animal studies) | 7 | $2.55/mg |
| Crystagen | Preclinical (lab and animal studies) | 5 | $3.00/mg |
| Eloralintide | Early human trials | 7 | $7.54/mg |
| GHK-Cu + KPV blend | Preclinical (lab and animal studies) | 8 | $0.983/mg |
| HGH Fragment 176-191 | Preclinical (lab and animal studies) | 15 | $8.99/mg |
| Livagen | Preclinical (lab and animal studies) | 7 | $2.72/mg |
| MGF | Preclinical (lab and animal studies) | 9 | $17.48/mg |
| N-Acetyl Selank Amidate | — | 14 | $4.00/mg |
| N-Acetyl Semax Amidate | Preclinical (lab and animal studies) | 15 | $3.50/mg |
| Ovagen | Preclinical (lab and animal studies) | 6 | $2.88/mg |
| P21 | Preclinical (lab and animal studies) | 11 | $7.75/mg |
| Pancragen | Preclinical (lab and animal studies) | 5 | $3.87/mg |
| PE-22-28 | Preclinical (lab and animal studies) | 23 | $5.00/mg |
| PEG-MGF | Preclinical (lab and animal studies) | 14 | $19.98/mg |
| Prostamax | Preclinical (lab and animal studies) | 11 | $3.00/mg |
| Semax + Selank blend | Early human trials | 19 | $4.81/mg |
| SLU-PP-332 | Preclinical (lab and animal studies) | 18 | $15.60/mg |
| Snap-8 | Preclinical (lab and animal studies) | 33 | $3.05/mg |
| Tesamorelin + Ipamorelin blend | Early human trials | 37 | $7.09/mg |
| Testagen | Preclinical (lab and animal studies) | 12 | $2.35/mg |
| Thymagen | Early human trials | 6 | $4.00/mg |
| Vesugen | Preclinical (lab and animal studies) | 12 | $3.20/mg |
| Vilon | Preclinical (lab and animal studies) | 9 | $2.72/mg |